Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Countries
Countries
USA
Products 121 to 130 of 188
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Myralene Renewable Solvent
by
Amyris
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/10/02 11:37 (7 years ago)
Known funding amount:
471,900,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
No longer on the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
AMRS
(NASDAQ)
Value chain stage:
Input
Myrifilm Zero-VOC Coalescing Solvent
by
GC Innovation America
+
Myriant
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/09/13 15:37 (7 years ago)
Known funding amount:
110,000,000 USD
Funding types:
Government
+
Venture Capital
Industry:
Industrial
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Myristoyl Glutamate (Surfactant)
by
Modular Genetics, Inc.
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
1,121,998 USD
Funding types:
Private Funding
+
University
+
Government
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Open Release
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Neossance Hemisqualane
by
Aprinnova
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
+
Japan
+
Europe
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
471,900,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Personal Care (Topical)
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
AMRS
(NASDAQ)
Value chain stage:
Finished Product
Neossance Squalane
by
Aprinnova
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
Australia
+
Canada
+
China
+
Europe
+
Japan
+
Korea
+
Mexico
+
New Zealand
+
Philippines
+
Russia
+
USA
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
471,900,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Personal Care (Topical)
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
AMRS
(NASDAQ)
Value chain stage:
Finished Product
Neuroscience Chip
by
Koniku
Biotech components:
Gene Editing
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Government
+
Consumer
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
1,650,980 USD
Funding types:
Venture Capital
Industry:
Food & Agriculture
+
Security
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Design
+
Food
+
Threat detection
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Platform
ON-OFF Switch for Biocontainment
by
Synvivia
Biotech components:
Animal
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
+
Canada
Intended consumer:
Commercial
+
Government
+
TBD
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
295,172 USD
Funding types:
Government
+
Venture Capital
Industry:
Food & Agriculture
+
Health
Market status:
Early Stage Concept
Organization type(s):
Private Company
Product categories:
Soil Amendment
+
Medical Treatment
+
Other (Industrial)
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
ON Technology
by
Pivot Bio
Biotech components:
Microbe
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/10/08 14:36 (7 years ago)
Known funding amount:
16,700,000 USD
Funding types:
Venture Capital
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Soil Amendment
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Personalized Probiotics
by
Thryve
Biotech components:
Bacteria
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/10/08 14:52 (7 years ago)
Known funding amount:
1,900,000 USD
Funding types:
Venture Capital
Industry:
Health
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Personal Care (Ingested)
Production process:
Closed Production
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Phyzyme XP Phytase
by
DuPont
+
Danisco
Biotech components:
Bacteria
Business models:
B2B
Country of production:
USA
+
Denmark
Country of distribution:
UK
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Feed
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
DWDP
(NYSE)
Value chain stage:
Input
1
…
8
9
10
11
12
13
14
15
16
17
…
19
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
